CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,359,736
- in 11 filings, $2.4M under 10b5-1 plans
Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-08-20 | Schrepfer Robert W VP Bus Dev & Con Mfg | Grant or award · Option to Purchase | +25,000 | 25,000 | ||
| 2014-06-18 | Marken James G. Vice President, Operations | Sale | −5,000 | $34.28 | $171K | 46,568 |
| 2014-05-22 | Marken James G. Vice President, Operations | Grant or award | +3,300 | 51,568 | ||
| 2014-05-22 | Marken James G. Vice President, Operations | Grant or award · Option to Purchase | +29,583 | 29,583 |
Page 41 of 41 · 804 trades